Tissue plasminogen activator (tPA) activity is a novel and early marker of asymptomatic LEAD in type 2 diabetes

Thrombosis Research

Volumn 123, Issue 5, 2009, Pages 701-706

  Sahli, David ^a   Eriksson, Jan W ^a,b   Boman, Kurt ^c   Svensson, Maria K ^a,d  

^a UMEÅ UNIVERSITY HOSPITAL   (Sweden)

^b ASTRAZENECA R AND D   (Sweden)

^c Skelleftea Hospital   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Ankle blood pressure; Diabetes mellitus; Fibrinolysis; Macroangiopathy; Toe blood pressure

Indexed keywords

HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TISSUE PLASMINOGEN ACTIVATOR; TRIACYLGLYCEROL;

ADULT; AGED; ARTERY DISEASE; ARTICLE; BLOOD PRESSURE MEASUREMENT; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETIC PATIENT; DISEASE ASSOCIATION; DISEASE MARKER; ENZYME ACTIVITY; FEMALE; FIBRINOLYSIS; HEMOGLOBIN BLOOD LEVEL; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; LEG ARTERY; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PERIPHERAL CIRCULATION; PRIORITY JOURNAL; SEX DIFFERENCE; TRIACYLGLYCEROL BLOOD LEVEL;

ADULT; AGED; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; BLOOD PRESSURE; DIABETES MELLITUS, TYPE 2; FEMALE; HUMANS; LOWER EXTREMITY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PERIPHERAL VASCULAR DISEASES; TISSUE PLASMINOGEN ACTIVATOR;

EID: 60449108486     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2008.07.015     Document Type: Article

References (35)

1. Fowkes F.G., Housley E., Cawood E.H., Macintyre C.C., Ruckley C.V., and Prescott R.J. Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population. Int J Epidemiol 20 (1991) 384-392
2. Selvin E., and Erlinger T.P. Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000. Circulation 110 (2004) 738-743
3. Stoffers H.E., Rinkens P.E., Kester A.D., Kaiser V., and Knottnerus J.A. The prevalence of asymptomatic and unrecognized peripheral arterial occlusive disease. Int J Epidemiol 25 (1996) 282-290
4. Weitz J.I., Byrne J., Clagett G.P., Farkouh M.E., Porter J.M., Sackett D.L., et al. Diagnosis and treatment of chronic arterial insufficiency of the lower extremities: a critical review. Circulation 94 (1996) 3026-3049
5. Hirsch A.T., Criqui M.H., Treat-Jacobson D., Regensteiner J.G., Creager M.A., Olin J.W., et al. Peripheral arterial disease detection, awareness, and treatment in primary care. Jama 286 (2001) 1317-1324
6. Raffetto J.D., Montgomery J.E., Eberhardt R.T., LaMorte W.W., and Menzoian J.O. Differences in risk factors for lower extremity arterial occlusive disease. J Am Coll Surg 201 (2005) 918-924
7. Nather A., Bee C.S., Huak C.Y., Chew J.L., Lin C.B., Neo S., et al. Epidemiology of diabetic foot problems and predictive factors for limb loss. J Diabetes Complicat 22 (2008) 77-82
8. Matzke S., and Lepantalo M. Claudication does not always precede critical leg ischemia. Vasc Med 6 (2001) 77-80
9. Peripheral arterial disease in people with diabetes. Diabetes Care 26 (2003) 3333-3341
10. Adler A.I., Stevens R.J., Neil A., Stratton I.M., Boulton A.J., and Holman R.R. UKPDS 59: hyperglycemia and other potentially modifiable risk factors for peripheral vascular disease in type 2 diabetes. Diabetes Care 25 (2002) 894-899
11. Dieter R.S., Chu W.W., Pacanowski Jr. J.P., McBride P.E., and Tanke T.E. The significance of lower extremity peripheral arterial disease. Clin Cardiol 25 (2002) 3-10
12. Criqui M.H. Peripheral arterial disease-epidemiological aspects. Vasc Med 6 (2001) 3-7
13. Fontbonne A., Eschwege E., Cambien F., Richard J.L., Ducimetiere P., Thibult N., et al. Hypertriglyceridaemia as a risk factor of coronary heart disease mortality in subjects with impaired glucose tolerance or diabetes. Results from the 11-year follow-up of the Paris Prospective Study. Diabetologia 32 (1989) 300-304
14. Gardner C.D., Fortmann S.P., and Krauss R.M. Association of small low-density lipoprotein particles with the incidence of coronary artery disease in men and women. Jama 276 (1996) 875-881
15. Lamarche B., Tchernof A., Moorjani S., Cantin B., Dagenais G.R., Lupien P.J., et al. Small, dense low-density lipoprotein particles as a predictor of the risk of ischemic heart disease in men. Prospective results from the Quebec Cardiovascular Study. Circulation 95 (1997) 69-75
16. Poredos P., Stegnar M., and Gacnik A. Alteration of the fibrinolytic system in patients with peripheral arterial occlusive disease. Vasa 28 (1999) 106-111
17. Schneider D.J., Nordt T.K., and Sobel B.E. Attenuated fibrinolysis and accelerated atherogenesis in type II diabetic patients. Diabetes 42 (1993) 1-7
18. Killewich L.A., Gardner A.W., Macko R.F., Hanna D.J., Goldberg A.P., Cox D.K., et al. Progressive intermittent claudication is associated with impaired fibrinolysis. J Vasc Surg 27 (1998) 645-650
19. Caputo M., Mantini G., Floriani I., Ciceri M., Noseda A., and Bonomo L. Tissue plasminogen activator, tissue plasminogen activator inhibitor and lipoprotein(a) in patients with coronary, epiaortic and peripheral occlusive artery disease. Eur Heart J 17 (1996) 1329-1336
20. Sofi F., Lari B., Rogolino A., Marcucci R., Pratesi G., Dorigo W., et al. Thrombophilic risk factors for symptomatic peripheral arterial disease. J Vasc Surg 41 (2005) 255-260
21. Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20 (1997) 1183-1197
22. Sahli D., Eliasson B., Svensson M., Blohme G., Eliasson M., Samuelsson P., et al. Assessment of toe blood pressure is an effective screening method to identify diabetes patients with lower extremity arterial disease. Angiology 55 (2004) 641-651
23. Samuelsson P., Blohme G., Fowelin J., and Eriksson J.W. A new non-invasive method using pulse oximetry for the assessment of arterial toe pressure. Clin Physiol 16 (1996) 463-467
24. Sahli D., Svensson M., Lidgren J., Ojbrandt K., and Eriksson J.W. Evaluation of simple non-invasive techniques for assessment of lower extremity arterial disease. Clin Physiol Funct Imaging 25 (2005) 129-134
25. Calles-Escandon J., and Cipolla M. Diabetes and endothelial dysfunction: a clinical perspective. Endocr Rev 22 (2001) 36-52
26. Speiser W., Speiser P., Minar E., Korninger C., Niessner H., Huber K., et al. Activation of coagulation and fibrinolysis in patients with arteriosclerosis: relation to localization of vessel disease and risk factors. Thromb Res 59 (1990) 77-88
27. Smith F.B., Lee A.J., Rumley A., Fowkes F.G., and Lowe G.D. Tissue-plasminogen activator, plasminogen activator inhibitor and risk of peripheral arterial disease. Atherosclerosis 115 (1995) 35-43
28. Johansson J., Egberg N., Johnsson H., and Carlson L.A. Serum lipoproteins and hemostatic function in intermittent claudication. Arterioscler Thromb 13 (1993) 1441-1448
29. Cortellaro M., Cofrancesco E., Boschetti C., Mussoni L., Donati M.B., Catalano M., et al. Association of increased fibrin turnover and defective fibrinolytic capacity with leg atherosclerosis. The PLAT Group. Thromb Haemost 72 (1994) 292-296
30. Maser R.E., Ellis D., Erbey J.R., and Orchard T.J. Do tissue plasminogen activator-plasminogen activator inhibitor-1 complexes relate to the complications of insulin-dependent diabetes mellitus? Pittsburgh Epidemiology of Diabetes Complications Study. J Diabetes Complicat 11 (1997) 243-249
31. Lapolla A., Piarulli F., Sartore G., Rossetti C., Martano L., Carraro P., et al. Peripheral artery disease in type 2 diabetes: the role of fibrinolysis. Thromb Haemost 89 (2003) 91-96
32. Tzoulaki I., Murray G.D., Price J.F., Smith F.B., Lee A.J., Rumley A., et al. Hemostatic factors, inflammatory markers, and progressive peripheral atherosclerosis: the Edinburgh Artery Study. Am J Epidemiol 163 (2006) 334-341
33. Vaughan D.E. PAI-1 and atherothrombosis. J Thromb Haemost 3 (2005) 1879-1883
34. Kooistra T., Schrauwen Y., Arts J., and Emeis J.J. Regulation of endothelial cell t-PA synthesis and release. Int J Hematol 59 (1994) 233-255
35. Eliasson M., Evrin P.E., Lundblad D., Asplund K., and Rånby M. Influence of gender, age and sampling time on plasma fibrinolytic variables and fibrinogen. Fibrinolysis 7 (1993) 316-323